Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

Market Cap	471.06M -16.3%
Revenue (ttm)	89.95M +5.1%
Net Income	3.81M -48.2%
EPS	0.01 -53.6%
Shares Out	n/a
PE Ratio	123.73
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,580
Open	0.7350
Previous Close	0.7850
Day's Range	0.7350 - 0.7350
52-Week Range	0.6900 - 2.1200
Beta	n/a
RSI	46.02
Earnings Date	Mar 30, 2026

About FRA:UJ9

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 714
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UJ9

Financial Performance

Financial numbers in CNY